首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
Authors:Walter Fiedler  Joerg Chromik  Stefanie Amberg  Maxim Kebenko  Felicitas Thol  Vera Schlipfenbacher  Anne Christine Wilke  Franziska Modemann  Melanie Janning  Hubert Serve  Arnold Ganser  Carsten Bokemeyer  Susann Theile  Ute Deppermann  Anne L. Kranich  Michael Heuser
Affiliation:1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;2. Medical Clinic II, Hematology, Hemostaseology, Medical Oncology, Rheumatology, Infectious Disease, University Hospital Frankfurt, Frankfurt, Germany;3. GSO Global Clinical Research B.V., Amsterdam, The Netherlands;4. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;5. GSO mbH, Hamburg, Germany
Abstract:
Keywords:acute myeloid leukaemia  clinical studies  chemotherapy  selinexor
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号